ARDT Stock Analysis: Buy, Sell, or Hold?
ARDT - Ardent Health, Inc.
$10.07
-0.01 (-0.10%)
▼
5d:
-6.93%
30d:
+8.05%
90d:
+7.13%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Get Alerted When ARDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARDT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ARDT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$11.41
Based on 4.8% avg growth
INTRINSIC VALUE TODAY
$7.08
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDT is currently trading at $10.07, which is considered slightly high relative to its 30-day fair value range of $9.00 to $10.23. From a valuation perspective, the stock is trading at a premium (Forward PE: 7.9) compared to its historical average (7.1). At these levels, the market is pricing in 3.7% annual earnings growth.
Technical Outlook: Technically, ARDT is in a uptrend. Immediate support is located at $9.44, while resistance sits at $11.03.
Market Sentiment: ARDT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.27 (+21.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARDT is in a uptrend. Immediate support is located at $9.44, while resistance sits at $11.03.
Market Sentiment: ARDT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.27 (+21.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$9.00 -
$10.23
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.9% below Wall St target ($12.27)
- BULLISH: Expecting earnings turnaround to 3.7% growth with 7.0% revenue growth
- CAUTION: Recommendation downgraded due to -6.9% 5-day decline
Trading Range Analysis
30-Day Trading Range
$9.00 -
$10.23
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.44
Resistance Level
$11.03
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.90
Wall Street Target
$12.27
(+21.9%)
Revenue Growth (YoY)
7.0%
Earnings Growth (YoY)
-3.4%
Profit Margin
2.1%
Valuation Premium vs History
+3.7% premium
PE vs Historical
7.9 vs 7.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.7%
(market-implied from PE analysis)
1-Year Target
$10.44
(+4%)
2-Year Target
$10.83
(+8%)
3-Year Target
$11.23
(+12%)
3-Yr Target (if PE normalizes)
(PE: 8→7)
PE COMPRESSION
$10.09
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 5.5%)
$32.59
(+224%)
Base:
(SPY PE: 7.9, Growth: 5.5%)
$11.83
(+17%)
Bear:
(PE: 6.7, Growth: 5.5%)
$10.05
(0%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 10.73 | Current EPS (TTM): $0.94
Bull Case
$15.04
(+49%)
Analyst growth 35.5%, PE expands to 11.8
Base Case
$13.68
(+36%)
Market implied 35.5%, PE stable at 10.7
Bear Case
$6.86
(-32%)
Severe decline -20.0%, PE contracts to 9.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 62 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$494 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 53 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 64 BUY |
